Health and FitnessHealth and Fitness
Wed, September 5, 2012
[ Wed, Sep 05th 2012 ] - Market Wire
RBCC Opens Up Deal Pipeline
Tue, September 4, 2012

MannKind Corporation to Present at Upcoming Conferences


Published on 2012-09-04 14:17:31 - Market Wire
  Print publication without navigation


VALENCIA, Calif.--([ ])--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences.

  • Rodman & Renshaw Annual Global Investment Conference on Monday, September 10, 2012 at 10:25 AM (ET) at the Waldorf-Astoria, New York City.
  • Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2012 at 10:55 AM (ET) at the Grand Hyatt New York, New York City.
  • Imperial Capital Global Opportunities Conference on Wednesday, September 19, 2012 at 12:30 PM (ET) at the Waldorf-Astoria, New York City.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at [ http://www.mannkindcorp.com ].

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at [ www.mannkindcorp.com ] to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.